Market Overview

Pharmacokinetics Services Market 2018 - Forecast to 2025

Share:

Dublin, Aug. 27, 2018 (GLOBE NEWSWIRE) -- The "Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules, Large Molecules (Biopharmaceuticals)), By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global pharmacokinetics services market size is expected to reach USD 1.2 billion by 2025, registering an 8.3% CAGR during the forecast period.

Rising adoption of pharmacokinetic and toxicology studies for determination of several parameters such as no-observed-effect levels (NOEL), human equivalent doses (HED) levels, and pharmacokinetic/pharmacodynamic (PK/PD) drivers are expected to fuel market growth.

Thorough understanding of the pharmacokinetic profile of a potential drug candidate plays a major role in the success of a drug discovery program. In addition to this, regulatory bodies have played a major role in the progress of this market through establishing defined guidelines for conducting PK studies. There are a substantial number of CROs engaged in conducting PK studies in accordance with relevant EMEA, ICH, FDA, GCP, and other regulatory guidelines.

Growing concern for effective implementation of PK services in the drug development process is anticipated to drive investments in this sector. Several conferences and certification courses are being conducted across the world to increase the understanding of various paradigms associated with pharmacokinetics application in clinical and preclinical drug development.

Further key findings from the report suggest:

  • Based on drug type, PK services for small molecules dominated the market in 2017 and is expected to maintain its lead during the forecast period fueled by high service penetration and growing popularity of generics
  • PK services for large molecules are expected to grow significantly during the forecast period, driven by presence of significant number of biologics and biosimilars in the clinical development phase
  • Presence of a large number of biopharmaceutical and pharmaceutical manufacturing entities in U.S. has resulted in North America accounting for the largest share in 2017
  • Asia Pacific is expected to grow lucratively throughout the forecast period thanks to constant economic growth in several countries, which has attracted significant attention from global CROs and resulted in business expansions
  • Pharmaceutical Product Development, LLC; Charles River Laboratories International, Inc.; PAREXEL International Corporation; and Eurofins Scientific, Inc. are some of the key service providers
  • These CROs are undertaking various initiatives in order to capitalize on new market avenues and enhance their share in the future market.

Key Topics Covered:

Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Research Methodology
2.1 Information procurement
2.2 Data Analysis

Chapter 3 Pharmacokinetics Services Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Focused efforts to establish a standardized pharmacokinetic monitoring approach
3.1.1.2 Robust drug pipeline and ongoing clinical studies
3.1.1.3 Conferences that aimed at growing awareness about the role of pharmacokinetics
3.1.2 Market restraint analysis
3.1.2.1 Limitations associated with in vitro PKPD studies
3.2 Penetration & Growth Prospect Mapping For Drug Type, 2017
3.3 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter's

Chapter 4 Pharmacokinetics Services Market: Drug Type Estimates & Trend Analysis
4.1 Pharmacokinetics Services Market: Drug Type Movement Analysis
4.2 Small Molecule Pharmacokinetics Services
4.3 Large Molecule Pharmacokinetic Services

Chapter 5 Pharmacokinetics Services Market: Regional Estimates & Trend Analysis, by Drug Type

Chapter 6 Competitive Landscape

  • Evotec AG
  • Certara, L.P.
  • Pacific BioLabs
  • GVK Biosciences Private Limited
  • Shanghai Medicilon Inc.
  • Pharmaceutical Product Development, LLC
  • Charles River Laboratories International, Inc.
  • PAREXEL International Corporation
  • Eurofins Scientific, Inc.
  • Frontage Labs
  • SGS SA
  • LGC Limited
  • Creative Bioarray

For more information about this report visit https://www.researchandmarkets.com/research/qbft8j/pharmacokinetics?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery

Primary Logo

View Comments and Join the Discussion!
 

Latest Ratings

StockFirmActionPT
LXFTKeyBancDowngrades0.0
CPAImperial CapitalDowngrades68.0
PRMWImperial CapitalInitiates Coverage On18.0
TGTKeyBancInitiates Coverage On110.0
QCOMMorgan StanleyUpgrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.